Breaking News
1 hour ago
Simantini Singh Deo
RenovoRx appoints UCLA pancreatic surgery expert Dr. Timothy Donahue to its Scientific Advisory Board to support advancements in targeted cancer therapies.
Simantini Singh Deo
Novo Nordisk partners with the U.S. Administration to cut semaglutide drug prices and expand Medicare coverage for obesity treatments from 2026.
Simantini Singh Deo
Nasus Pharma receives Health Canada clearance to begin Phase 2 trial of NS002, its intranasal epinephrine powder for treating anaphylaxis.
Simantini Singh Deo
Coherus Oncology appoints Arvind Sood as Chief Strategy and Corporate Affairs Officer to drive strategic growth and investor engagement.
Simantini Singh Deo